SARS-CoV-2 spike mutation L452R evades human immune response and enhances infectivity, researchers f …

sars cov 2 spike mutation l452r evades human immune response and enhances infectivity researchers find

Sumary of SARS-CoV-2 spike mutation L452R evades human immune response and enhances infectivity, researchers find:

  • An international team of researchers led by Kumamoto and Tokyo Universities (Japan) have shown that the L452R mutation of the SARS-CoV-2 spike protein, which is common to two mutant strains (Epsilon and Delta), is involved in cellular immunity evasion via the human leukocyte antigen (HLA) A24, and enhances viral infectivity.
  • HLA-A24 is one of the most prominent HLA-class I alleles, especially in East/Southeast Asian populations, which might make them particularly vulnerable to coronavirus variants with this mutation.
  • Acquired immunity can be broadly classified into humoral immunity mediated by neutralizing antibodies and cellular immunity mediated by helper and killer T cells.
  • SARS-CoV-2 “variants of concern,” such as the Alpha and Beta variants, have been studied worldwide for the possibility of humoral immunity evasion.
  • In this study, the research group first used immunological experiments to demonstrate that an antigen derived from the SARS-CoV-2 spike protein is strongly recognized by HLA-A24-restricted cellular immunity, which is often found in Japanese people.
  • They then performed a large-scale (>750,000) sequence analysis of SARS-CoV-2 strains and found several important mutations in the spike protein region typically recognized by HLA-A24. These are the Y453F spike mutations found in strain B.
  • Further immunological experiments demonstrated that these mutations escape HLA-A24 cellular immunity.
  • The researchers believe that this is the first time a “variant of concern” has been demonstrated to evade cellular immunity.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close